Last reviewed · How we verify

dl-alpha-tocopherol — Competitive Intelligence Brief

dl-alpha-tocopherol (dl-alpha-tocopherol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin E derivative. Area: Oncology, Neurology.

phase 3 Vitamin E derivative Oncology, Neurology Small molecule Live · refreshed every 30 min

Target snapshot

dl-alpha-tocopherol (dl-alpha-tocopherol) — US Department of Veterans Affairs. dl-alpha-tocopherol acts as an antioxidant by scavenging free radicals and protecting cells from oxidative damage.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
dl-alpha-tocopherol TARGET dl-alpha-tocopherol US Department of Veterans Affairs phase 3 Vitamin E derivative

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin E derivative class)

  1. US Department of Veterans Affairs · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). dl-alpha-tocopherol — Competitive Intelligence Brief. https://druglandscape.com/ci/dl-alpha-tocopherol. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: